EAPI Euroapi S.A.

0.7480USD0.6820 EUR · EPA-1.02%Mkt Cap: 71.46M USDP/E: —

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North…

Institutional holders10 on file

Key Statistics

Company
Market Cap71.46M USD
Enterprise Value133.97M USD
Revenue (TTM)871.52M USD
Gross Profit158.82M USD
Net Income (TTM)-231.64M USD
Revenue/Share9.20 USD
Last Price0.7480 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.0K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINFR0014008VX5
Valuation
P/E (Trailing)—
P/E (Forward)-3.19
PEG—
EV/EBITDA0.93
EV/Revenue0.15
P/S0.08
P/B0.14
EPS (TTM)-3.75 USD
EPS (Forward)-0.23 USD
52W Range
0.72501% of range3.600
52W High3.600 USD
52W Low0.7250 USD
Profitability
Gross Margin16.98%
Oper. Margin-2.52%
EBITDA Margin16.63%
Profit Margin-24.77%
ROE-26.80%
ROA-16.19%
ROIC0.23%
ROCE0.17%
Growth
Revenue Growth-14.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF140.94M USD
CapEx (TTM)86.10M USD
FCF Margin19.21%
FCF Yield234.28%
Net Debt62.52M USD
Net Debt/EBITDA0.43
Net Debt/FCF0.37
Balance Sheet
Debt/Equity0.08
Current Ratio2.01
Quick Ratio0.53
Book Value/Sh5.37 USD
Cash/Share0.60 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.097 USD
Upside (mean)+46.6%
Target Range0.7678 USD – 1.536 USD
0.7678+46.6% to mean1.536
# Analysts4
Ownership
Shares Out.95.53M
Float50.80M
Insiders34.84%
Institutions35.58%
Technical
SMA 500.8510 (-12.1%)
SMA 2001.306 (-42.7%)
Beta0.98
S&P 52W Chg12.00%
Avg Vol (30d)186.57K
Avg Vol (10d)240.11K
Technical Indicators
RSI (14)30.9
MACD-0.0238
MACD Signal-0.0110
MACD Hist.-0.0128
BB Upper0.9564 USD
BB Middle0.8516 USD
BB Lower0.7468 USD
BB Width24.62%
ATR (14)0.0366 USD
Vol Ratio (20d)0.27x

About Euroapi (EPA: EAPI)

›

Euroapi (EPA: EAPI) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 3,000 employees.

The shares were at 0.6820 EUR on 19 November 2026, down 78.2% over 52 weeks. Its 52-week range is 0.6610 EUR to 3.282 EUR: the price is 79.2% below the high and 3.2% above the low.

Its market capitalisation is 65.15M EUR.

Euroapi reports return on equity of -26.8%, an operating margin of -2.5% and revenue down 14.0% year over year.

Its debt exceeds its cash by 57.00M EUR, a debt-to-equity ratio of 0.08. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 4 analysts cover the stock; their mean price target of 1.000 EUR is 46.6% above the current price. The next earnings report is expected on 3 March 2027.